Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer. 2004

Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
Institute of Cytology and Preventive Oncology (ICMR), Maulana Azad Medical College Campus, Bahadur Shah Zafar Marg, New Delhi 110 002, India.

Breast cancer tissues from 271 cases were analyzed immunologically for c-erbB-2 oncoprotein (HER-2/neu), epidermal growth factor receptor (EGF-R) and estrogen receptor (ER). Overexpression of both c-erbB-2 oncoprotein and EGF-R showed an inverse association with ER and a direct association with metastatic involvement of lymph node and high histological grade. The frequency of c-erbB-2 and EGF-R overexpression was significantly higher among postmenopausal cases in comparison with premenopausal cases. Further, only in postmenopausal patients, c-erbB-2 oncoprotein (chi2 = 6.4, P < 0.05) and EGF-R (chi2 = 6.4, p < 0.05) as well as their concomitant expression (chi2 = 11.5, p < 0.01) revealed a statistically significant association with ER.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017697 Premenopause The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty. Pre-Menopause,Pre-menopausal Period,Premenopausal Period,Period, Pre-menopausal

Related Publications

Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
March 1991, British journal of cancer,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
January 1997, Anticancer research,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
December 1991, Breast cancer research and treatment,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
January 2000, Anticancer research,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
November 1996, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
August 1992, Clinical chemistry,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
January 1990, Cancer,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
January 2000, Tumori,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
January 2000, Journal of surgical oncology,
Amitabha Ray, and Bhuvnesh Kumar Sharma, and Sudershan Kaur, and Shashi Sharma, and Joginder Kumar Sharma
January 1999, The International journal of biological markers,
Copied contents to your clipboard!